Literature DB >> 991144

Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro.

J L Lichtenfeld, M R Desner, P H Wiernik, M R Mardiney.   

Abstract

Human lymphocytes were cultured in vitro with multiple concentrations of antigen, mitogen, and allogeneic cells. The addition of levamisole to stimulated cultures in concentrations of 0.03-33 mug/ml significantly amplified the response of lymphocytes to these stimuli with little or no effect on control cultures. The combination of stimulus and levamisole concentration which produced amplification was unique for each individual culture. The inconsistent results found here and elsewhere may reflect instability of levamisole under conditions of the in vitro lymphocyte culture system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991144

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

1.  The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant.

Authors:  E E Abdalla; I J Adam; G E Blair; A Boylston; H M Sue-Ling; P Finan; D Johnston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

2.  Restoration by levamisole of immune responses suppressed in tumor-bearing mice.

Authors:  M Shiraishi; K Himeno; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  In vivo effect of levamisole on cellular and humoral immunity in normal chickens.

Authors:  E Soppi; O Lassila; M K Viljanen; O P Lehtonen; J Eskola
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

4.  Human monocyte-lymphocyte interaction and its enhancement by levamisole.

Authors:  J W Kazura; W Negendank; D Guerry; A D Schreiber
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

5.  Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.

Authors:  R B Faanes; P Dillon; Y S Choi
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.